DLG2
Basic information
Region (hg38): 11:83455012-85628335
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DLG2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | |||||
missense | 32 | 35 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 35 | 9 | 6 |
Variants in DLG2
This is a list of pathogenic ClinVar variants found in the DLG2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-83459873-A-G | not specified | Uncertain significance (Jul 08, 2022) | ||
11-83459894-A-G | not specified | Uncertain significance (Oct 13, 2023) | ||
11-83459914-T-C | Benign (Jul 31, 2018) | |||
11-83469202-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
11-83469205-T-C | not specified | Uncertain significance (May 20, 2024) | ||
11-83471660-A-G | Benign/Likely benign (Jun 01, 2022) | |||
11-83471683-G-C | not specified | Uncertain significance (May 08, 2023) | ||
11-83471683-G-T | Benign (Jul 31, 2018) | |||
11-83471718-G-A | not specified | Uncertain significance (Dec 06, 2021) | ||
11-83484146-T-C | not specified | Uncertain significance (Aug 15, 2023) | ||
11-83484168-T-C | not specified | Uncertain significance (Mar 20, 2024) | ||
11-83484229-CTG-C | DLG2-related disorder | Uncertain significance (Oct 27, 2022) | ||
11-83541830-C-A | DLG2-related disorder | Uncertain significance (Jul 12, 2023) | ||
11-83633227-G-A | not specified | Uncertain significance (Dec 13, 2022) | ||
11-83786686-TGACC-T | DLG2-related disorder | Uncertain significance (Jun 07, 2023) | ||
11-83786731-G-T | not specified | Uncertain significance (Jan 22, 2024) | ||
11-83786734-C-G | not specified | Uncertain significance (May 24, 2023) | ||
11-83786766-T-A | Benign (Jul 31, 2018) | |||
11-83786767-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
11-83833643-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
11-83833699-C-T | not specified | Uncertain significance (Jun 03, 2022) | ||
11-83874429-G-A | not specified | Uncertain significance (Sep 21, 2023) | ||
11-83874439-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
11-83874444-A-G | not specified | Likely benign (Sep 18, 2015) | ||
11-83874451-T-C | not specified | Likely benign (May 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DLG2 | protein_coding | protein_coding | ENST00000376104 | 26 | 2172912 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.708 | 0.292 | 125522 | 0 | 11 | 125533 | 0.0000438 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.08 | 400 | 535 | 0.747 | 0.0000287 | 6384 |
Missense in Polyphen | 202 | 312.59 | 0.64622 | 3667 | ||
Synonymous | 0.757 | 182 | 195 | 0.931 | 0.0000111 | 1814 |
Loss of Function | 5.71 | 13 | 61.2 | 0.212 | 0.00000372 | 689 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000220 | 0.000213 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000557 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000442 | 0.0000440 |
Middle Eastern | 0.0000557 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for perception of chronic pain through NMDA receptor signaling. Regulates surface expression of NMDA receptors in dorsal horn neurons of the spinal cord. Interacts with the cytoplasmic tail of NMDA receptor subunits as well as inward rectifying potassium channels. Involved in regulation of synaptic stability at cholinergic synapses. Part of the postsynaptic protein scaffold of excitatory synapses (By similarity). {ECO:0000250}.;
- Pathway
- Tight junction - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- 0.145
- rvis_EVS
- -1.6
- rvis_percentile_EVS
- 3.04
Haploinsufficiency Scores
- pHI
- 0.986
- hipred
- Y
- hipred_score
- 0.706
- ghis
- 0.638
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.687
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dlg2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- MAPK cascade;chemical synaptic transmission;negative regulation of phosphatase activity;sensory perception of pain;cellular response to potassium ion;receptor clustering;establishment or maintenance of epithelial cell apical/basal polarity;GMP metabolic process;GDP metabolic process;receptor localization to synapse;cell-cell adhesion;maintenance of postsynaptic density structure;anterograde axonal protein transport;retrograde axonal protein transport;neurotransmitter receptor localization to postsynaptic specialization membrane
- Cellular component
- cytosol;plasma membrane;voltage-gated potassium channel complex;ionotropic glutamate receptor complex;postsynaptic density;membrane;basolateral plasma membrane;cell junction;neuromuscular junction;neuron projection;juxtaparanode region of axon;postsynaptic density membrane;glutamatergic synapse;axon cytoplasm
- Molecular function
- guanylate kinase activity;Ras guanyl-nucleotide exchange factor activity;protein binding;kinase binding;ionotropic glutamate receptor binding;structural constituent of postsynaptic density